Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
Conference
Mehta, M, Wang, M, Aldape, K et al. (2011). Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
. EUROPEAN JOURNAL OF CANCER, 47 10-10. 10.1016/S0959-8049(11)70117-4
Mehta, M, Wang, M, Aldape, K et al. (2011). Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
. EUROPEAN JOURNAL OF CANCER, 47 10-10. 10.1016/S0959-8049(11)70117-4